Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma

•Split bolus protocols may be suitable for pancreatic- and cholangiocarcinoma.•The split bolus protocol provides sufficient levels of diagnostic accuracy.•Split bolus protocol is equal to the multiphase protocol regarding image quality.•The split bolus protocol lowers the radiation exposure signific...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of radiology 2019-10, Vol.119, p.108626-108626, Article 108626
Hauptverfasser: Muenzfeld, Hanna, Mahjoub, Samy, Roehle, Robert, Pelzer, Uwe, Bahra, Marcus, Boening, Georg, Hamm, Bernd, Geisel, Dominik, Auer, Timo Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 108626
container_issue
container_start_page 108626
container_title European journal of radiology
container_volume 119
creator Muenzfeld, Hanna
Mahjoub, Samy
Roehle, Robert
Pelzer, Uwe
Bahra, Marcus
Boening, Georg
Hamm, Bernd
Geisel, Dominik
Auer, Timo Alexander
description •Split bolus protocols may be suitable for pancreatic- and cholangiocarcinoma.•The split bolus protocol provides sufficient levels of diagnostic accuracy.•Split bolus protocol is equal to the multiphase protocol regarding image quality.•The split bolus protocol lowers the radiation exposure significantly.•Split bolus protocols in computed tomography are easy and safe to perform. To investigate the image quality, diagnostic accuracy, and dose reduction potential of a split-bolus protocol(SBP) compared with a multiphasic protocol(MPP) in the detection of recurrent or progressive pancreatic ductal adenocarcinoma(PDAC) or cholangiocarcinoma(CC) using contrast- enhanced computed tomography(CECT). This prospective study included 56 patients who underwent CECT, 28 with our institutional standard MPP(100 ml contrast bolus) and 28 with a novel SBP(110 ml). Radiation exposure was determined in terms of total dose- length product(DLP) and computed tomography dose index(CTDI). Image quality was measured objectively by analysis of attenuation in Hounsfield units(HU) in regions of interest(ROIs) and subjectively by two blinded readers using a Likert scale. Diagnostic accuracy and interreader variability were tested. The total DLP of the SBP group(498.1 ± 43.7 mGy*cm) was significantly lower than in the MPP group(1,092.5 ± 106.9 mGy*cm; p 
doi_str_mv 10.1016/j.ejrad.2019.07.027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2280565465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0720048X19302700</els_id><sourcerecordid>2280565465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-591c1420fb41572f107a4bd09869b877d8262e9d2060a4e8dd1f34c80d09f3043</originalsourceid><addsrcrecordid>eNp9kMtOxCAUhonR6Hh5AhPD0k3rgdLSLlwY4y0xcaEm7ggF6jBpSwU6xrcXHXXpitv3n3P4EDomkBMg1dkqNysvdU6BNDnwHCjfQgtSc5pxTvk2WgCnkAGrX_bQfggrAChZQ3fRXkFYAVVFFqh_nHobs9b1c8DrkONh7qOdljJYhZUbo5ch4s3z5F10yvXYjniS0ZoxBvxu4zKdRuVNukqZtDUeO4_V0vVyfLVOSa_s6AZ5iHY62Qdz9LMeoOfrq6fL2-z-4ebu8uI-U0XZxKxsiCKMQtcyUnLaEeCStRqaumramnNd04qaRlOoQDJTa026gqkaEtIVwIoDdLqpmyZ-m02IYrBBmT6NY9wcBKU1lFXJqjKhxQZV3oXgTScmbwfpPwQB8aVZrMS3ZvGlWQAXSXNKnfw0mNvB6L_Mr9cEnG8Ak765tsaLoJIvZbT1RkWhnf23wSfGC5CH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2280565465</pqid></control><display><type>article</type><title>Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Muenzfeld, Hanna ; Mahjoub, Samy ; Roehle, Robert ; Pelzer, Uwe ; Bahra, Marcus ; Boening, Georg ; Hamm, Bernd ; Geisel, Dominik ; Auer, Timo Alexander</creator><creatorcontrib>Muenzfeld, Hanna ; Mahjoub, Samy ; Roehle, Robert ; Pelzer, Uwe ; Bahra, Marcus ; Boening, Georg ; Hamm, Bernd ; Geisel, Dominik ; Auer, Timo Alexander</creatorcontrib><description>•Split bolus protocols may be suitable for pancreatic- and cholangiocarcinoma.•The split bolus protocol provides sufficient levels of diagnostic accuracy.•Split bolus protocol is equal to the multiphase protocol regarding image quality.•The split bolus protocol lowers the radiation exposure significantly.•Split bolus protocols in computed tomography are easy and safe to perform. To investigate the image quality, diagnostic accuracy, and dose reduction potential of a split-bolus protocol(SBP) compared with a multiphasic protocol(MPP) in the detection of recurrent or progressive pancreatic ductal adenocarcinoma(PDAC) or cholangiocarcinoma(CC) using contrast- enhanced computed tomography(CECT). This prospective study included 56 patients who underwent CECT, 28 with our institutional standard MPP(100 ml contrast bolus) and 28 with a novel SBP(110 ml). Radiation exposure was determined in terms of total dose- length product(DLP) and computed tomography dose index(CTDI). Image quality was measured objectively by analysis of attenuation in Hounsfield units(HU) in regions of interest(ROIs) and subjectively by two blinded readers using a Likert scale. Diagnostic accuracy and interreader variability were tested. The total DLP of the SBP group(498.1 ± 43.7 mGy*cm) was significantly lower than in the MPP group(1,092.5 ± 106.9 mGy*cm; p &lt; 0.001). The SBP showed higher contrast enhancement of all critical anatomical structures including portal vein, liver, and pancreas compared with the MPP, except for the aorta(SBP: 326.9 ± 15.7 HU vs. MPP: 246.7 ± 12.2 HU; p &lt; 0.001). Subjective analysis revealed poorer image quality ratings for important landmarks with the MPP (resection surface: p = 0.624, portal vein: p = 0.395, liver p = 0.361). The two blinded readers correlated significantly. Sensitivity, specificity, positive and negative predictive values (PPV/NPV), and overall interreader variabilities correlated significantly. Furthermore, significantly fewer slices per exam were required for the SBP(1,823 vs. 3,235; p &lt; 0.001). The SBP provides the same image quality and diagnostic accuracy as an MPP while significantly lowering radiation exposure in CT follow-up of PDAC or CC.</description><identifier>ISSN: 0720-048X</identifier><identifier>EISSN: 1872-7727</identifier><identifier>DOI: 10.1016/j.ejrad.2019.07.027</identifier><identifier>PMID: 31430661</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Aged ; Bile Duct Neoplasms - diagnostic imaging ; Bile Ducts - diagnostic imaging ; Bile Ducts - radiation effects ; Carcinoma, Pancreatic Ductal - diagnostic imaging ; Cholangiocarcinoma ; Cholangiocarcinoma - diagnostic imaging ; Clinical Protocols ; Contrast Media - administration &amp; dosage ; Dose reduction ; Female ; Humans ; Iohexol - administration &amp; dosage ; Iohexol - analogs &amp; derivatives ; Iopamidol - administration &amp; dosage ; Iopamidol - analogs &amp; derivatives ; Liver - diagnostic imaging ; Liver - radiation effects ; Male ; Multidetector Computed Tomography - methods ; Neoplasm Recurrence, Local - diagnostic imaging ; Pancreas - diagnostic imaging ; Pancreas - radiation effects ; Pancreatic cancer ; Pancreatic Neoplasms - diagnostic imaging ; Portal Vein - diagnostic imaging ; Portal Vein - radiation effects ; Prospective Studies ; Radiation Dosage ; Radiation Exposure ; Sensitivity and Specificity ; Split-bolus CT ; Split-bolus technique</subject><ispartof>European journal of radiology, 2019-10, Vol.119, p.108626-108626, Article 108626</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-591c1420fb41572f107a4bd09869b877d8262e9d2060a4e8dd1f34c80d09f3043</citedby><cites>FETCH-LOGICAL-c359t-591c1420fb41572f107a4bd09869b877d8262e9d2060a4e8dd1f34c80d09f3043</cites><orcidid>0000-0002-5763-689X ; 0000-0001-5151-1853</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0720048X19302700$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31430661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muenzfeld, Hanna</creatorcontrib><creatorcontrib>Mahjoub, Samy</creatorcontrib><creatorcontrib>Roehle, Robert</creatorcontrib><creatorcontrib>Pelzer, Uwe</creatorcontrib><creatorcontrib>Bahra, Marcus</creatorcontrib><creatorcontrib>Boening, Georg</creatorcontrib><creatorcontrib>Hamm, Bernd</creatorcontrib><creatorcontrib>Geisel, Dominik</creatorcontrib><creatorcontrib>Auer, Timo Alexander</creatorcontrib><title>Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma</title><title>European journal of radiology</title><addtitle>Eur J Radiol</addtitle><description>•Split bolus protocols may be suitable for pancreatic- and cholangiocarcinoma.•The split bolus protocol provides sufficient levels of diagnostic accuracy.•Split bolus protocol is equal to the multiphase protocol regarding image quality.•The split bolus protocol lowers the radiation exposure significantly.•Split bolus protocols in computed tomography are easy and safe to perform. To investigate the image quality, diagnostic accuracy, and dose reduction potential of a split-bolus protocol(SBP) compared with a multiphasic protocol(MPP) in the detection of recurrent or progressive pancreatic ductal adenocarcinoma(PDAC) or cholangiocarcinoma(CC) using contrast- enhanced computed tomography(CECT). This prospective study included 56 patients who underwent CECT, 28 with our institutional standard MPP(100 ml contrast bolus) and 28 with a novel SBP(110 ml). Radiation exposure was determined in terms of total dose- length product(DLP) and computed tomography dose index(CTDI). Image quality was measured objectively by analysis of attenuation in Hounsfield units(HU) in regions of interest(ROIs) and subjectively by two blinded readers using a Likert scale. Diagnostic accuracy and interreader variability were tested. The total DLP of the SBP group(498.1 ± 43.7 mGy*cm) was significantly lower than in the MPP group(1,092.5 ± 106.9 mGy*cm; p &lt; 0.001). The SBP showed higher contrast enhancement of all critical anatomical structures including portal vein, liver, and pancreas compared with the MPP, except for the aorta(SBP: 326.9 ± 15.7 HU vs. MPP: 246.7 ± 12.2 HU; p &lt; 0.001). Subjective analysis revealed poorer image quality ratings for important landmarks with the MPP (resection surface: p = 0.624, portal vein: p = 0.395, liver p = 0.361). The two blinded readers correlated significantly. Sensitivity, specificity, positive and negative predictive values (PPV/NPV), and overall interreader variabilities correlated significantly. Furthermore, significantly fewer slices per exam were required for the SBP(1,823 vs. 3,235; p &lt; 0.001). The SBP provides the same image quality and diagnostic accuracy as an MPP while significantly lowering radiation exposure in CT follow-up of PDAC or CC.</description><subject>Aged</subject><subject>Bile Duct Neoplasms - diagnostic imaging</subject><subject>Bile Ducts - diagnostic imaging</subject><subject>Bile Ducts - radiation effects</subject><subject>Carcinoma, Pancreatic Ductal - diagnostic imaging</subject><subject>Cholangiocarcinoma</subject><subject>Cholangiocarcinoma - diagnostic imaging</subject><subject>Clinical Protocols</subject><subject>Contrast Media - administration &amp; dosage</subject><subject>Dose reduction</subject><subject>Female</subject><subject>Humans</subject><subject>Iohexol - administration &amp; dosage</subject><subject>Iohexol - analogs &amp; derivatives</subject><subject>Iopamidol - administration &amp; dosage</subject><subject>Iopamidol - analogs &amp; derivatives</subject><subject>Liver - diagnostic imaging</subject><subject>Liver - radiation effects</subject><subject>Male</subject><subject>Multidetector Computed Tomography - methods</subject><subject>Neoplasm Recurrence, Local - diagnostic imaging</subject><subject>Pancreas - diagnostic imaging</subject><subject>Pancreas - radiation effects</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - diagnostic imaging</subject><subject>Portal Vein - diagnostic imaging</subject><subject>Portal Vein - radiation effects</subject><subject>Prospective Studies</subject><subject>Radiation Dosage</subject><subject>Radiation Exposure</subject><subject>Sensitivity and Specificity</subject><subject>Split-bolus CT</subject><subject>Split-bolus technique</subject><issn>0720-048X</issn><issn>1872-7727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOxCAUhonR6Hh5AhPD0k3rgdLSLlwY4y0xcaEm7ggF6jBpSwU6xrcXHXXpitv3n3P4EDomkBMg1dkqNysvdU6BNDnwHCjfQgtSc5pxTvk2WgCnkAGrX_bQfggrAChZQ3fRXkFYAVVFFqh_nHobs9b1c8DrkONh7qOdljJYhZUbo5ch4s3z5F10yvXYjniS0ZoxBvxu4zKdRuVNukqZtDUeO4_V0vVyfLVOSa_s6AZ5iHY62Qdz9LMeoOfrq6fL2-z-4ebu8uI-U0XZxKxsiCKMQtcyUnLaEeCStRqaumramnNd04qaRlOoQDJTa026gqkaEtIVwIoDdLqpmyZ-m02IYrBBmT6NY9wcBKU1lFXJqjKhxQZV3oXgTScmbwfpPwQB8aVZrMS3ZvGlWQAXSXNKnfw0mNvB6L_Mr9cEnG8Ak765tsaLoJIvZbT1RkWhnf23wSfGC5CH</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Muenzfeld, Hanna</creator><creator>Mahjoub, Samy</creator><creator>Roehle, Robert</creator><creator>Pelzer, Uwe</creator><creator>Bahra, Marcus</creator><creator>Boening, Georg</creator><creator>Hamm, Bernd</creator><creator>Geisel, Dominik</creator><creator>Auer, Timo Alexander</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5763-689X</orcidid><orcidid>https://orcid.org/0000-0001-5151-1853</orcidid></search><sort><creationdate>201910</creationdate><title>Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma</title><author>Muenzfeld, Hanna ; Mahjoub, Samy ; Roehle, Robert ; Pelzer, Uwe ; Bahra, Marcus ; Boening, Georg ; Hamm, Bernd ; Geisel, Dominik ; Auer, Timo Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-591c1420fb41572f107a4bd09869b877d8262e9d2060a4e8dd1f34c80d09f3043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Bile Duct Neoplasms - diagnostic imaging</topic><topic>Bile Ducts - diagnostic imaging</topic><topic>Bile Ducts - radiation effects</topic><topic>Carcinoma, Pancreatic Ductal - diagnostic imaging</topic><topic>Cholangiocarcinoma</topic><topic>Cholangiocarcinoma - diagnostic imaging</topic><topic>Clinical Protocols</topic><topic>Contrast Media - administration &amp; dosage</topic><topic>Dose reduction</topic><topic>Female</topic><topic>Humans</topic><topic>Iohexol - administration &amp; dosage</topic><topic>Iohexol - analogs &amp; derivatives</topic><topic>Iopamidol - administration &amp; dosage</topic><topic>Iopamidol - analogs &amp; derivatives</topic><topic>Liver - diagnostic imaging</topic><topic>Liver - radiation effects</topic><topic>Male</topic><topic>Multidetector Computed Tomography - methods</topic><topic>Neoplasm Recurrence, Local - diagnostic imaging</topic><topic>Pancreas - diagnostic imaging</topic><topic>Pancreas - radiation effects</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - diagnostic imaging</topic><topic>Portal Vein - diagnostic imaging</topic><topic>Portal Vein - radiation effects</topic><topic>Prospective Studies</topic><topic>Radiation Dosage</topic><topic>Radiation Exposure</topic><topic>Sensitivity and Specificity</topic><topic>Split-bolus CT</topic><topic>Split-bolus technique</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muenzfeld, Hanna</creatorcontrib><creatorcontrib>Mahjoub, Samy</creatorcontrib><creatorcontrib>Roehle, Robert</creatorcontrib><creatorcontrib>Pelzer, Uwe</creatorcontrib><creatorcontrib>Bahra, Marcus</creatorcontrib><creatorcontrib>Boening, Georg</creatorcontrib><creatorcontrib>Hamm, Bernd</creatorcontrib><creatorcontrib>Geisel, Dominik</creatorcontrib><creatorcontrib>Auer, Timo Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muenzfeld, Hanna</au><au>Mahjoub, Samy</au><au>Roehle, Robert</au><au>Pelzer, Uwe</au><au>Bahra, Marcus</au><au>Boening, Georg</au><au>Hamm, Bernd</au><au>Geisel, Dominik</au><au>Auer, Timo Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma</atitle><jtitle>European journal of radiology</jtitle><addtitle>Eur J Radiol</addtitle><date>2019-10</date><risdate>2019</risdate><volume>119</volume><spage>108626</spage><epage>108626</epage><pages>108626-108626</pages><artnum>108626</artnum><issn>0720-048X</issn><eissn>1872-7727</eissn><abstract>•Split bolus protocols may be suitable for pancreatic- and cholangiocarcinoma.•The split bolus protocol provides sufficient levels of diagnostic accuracy.•Split bolus protocol is equal to the multiphase protocol regarding image quality.•The split bolus protocol lowers the radiation exposure significantly.•Split bolus protocols in computed tomography are easy and safe to perform. To investigate the image quality, diagnostic accuracy, and dose reduction potential of a split-bolus protocol(SBP) compared with a multiphasic protocol(MPP) in the detection of recurrent or progressive pancreatic ductal adenocarcinoma(PDAC) or cholangiocarcinoma(CC) using contrast- enhanced computed tomography(CECT). This prospective study included 56 patients who underwent CECT, 28 with our institutional standard MPP(100 ml contrast bolus) and 28 with a novel SBP(110 ml). Radiation exposure was determined in terms of total dose- length product(DLP) and computed tomography dose index(CTDI). Image quality was measured objectively by analysis of attenuation in Hounsfield units(HU) in regions of interest(ROIs) and subjectively by two blinded readers using a Likert scale. Diagnostic accuracy and interreader variability were tested. The total DLP of the SBP group(498.1 ± 43.7 mGy*cm) was significantly lower than in the MPP group(1,092.5 ± 106.9 mGy*cm; p &lt; 0.001). The SBP showed higher contrast enhancement of all critical anatomical structures including portal vein, liver, and pancreas compared with the MPP, except for the aorta(SBP: 326.9 ± 15.7 HU vs. MPP: 246.7 ± 12.2 HU; p &lt; 0.001). Subjective analysis revealed poorer image quality ratings for important landmarks with the MPP (resection surface: p = 0.624, portal vein: p = 0.395, liver p = 0.361). The two blinded readers correlated significantly. Sensitivity, specificity, positive and negative predictive values (PPV/NPV), and overall interreader variabilities correlated significantly. Furthermore, significantly fewer slices per exam were required for the SBP(1,823 vs. 3,235; p &lt; 0.001). The SBP provides the same image quality and diagnostic accuracy as an MPP while significantly lowering radiation exposure in CT follow-up of PDAC or CC.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31430661</pmid><doi>10.1016/j.ejrad.2019.07.027</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5763-689X</orcidid><orcidid>https://orcid.org/0000-0001-5151-1853</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0720-048X
ispartof European journal of radiology, 2019-10, Vol.119, p.108626-108626, Article 108626
issn 0720-048X
1872-7727
language eng
recordid cdi_proquest_miscellaneous_2280565465
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Bile Duct Neoplasms - diagnostic imaging
Bile Ducts - diagnostic imaging
Bile Ducts - radiation effects
Carcinoma, Pancreatic Ductal - diagnostic imaging
Cholangiocarcinoma
Cholangiocarcinoma - diagnostic imaging
Clinical Protocols
Contrast Media - administration & dosage
Dose reduction
Female
Humans
Iohexol - administration & dosage
Iohexol - analogs & derivatives
Iopamidol - administration & dosage
Iopamidol - analogs & derivatives
Liver - diagnostic imaging
Liver - radiation effects
Male
Multidetector Computed Tomography - methods
Neoplasm Recurrence, Local - diagnostic imaging
Pancreas - diagnostic imaging
Pancreas - radiation effects
Pancreatic cancer
Pancreatic Neoplasms - diagnostic imaging
Portal Vein - diagnostic imaging
Portal Vein - radiation effects
Prospective Studies
Radiation Dosage
Radiation Exposure
Sensitivity and Specificity
Split-bolus CT
Split-bolus technique
title Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T10%3A39%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Split-bolus%20vs.%20multiphasic%20contrast%20bolus%20protocol%20in%20patients%20with%20pancreatic%20cancer%20or%20cholangiocarcinoma&rft.jtitle=European%20journal%20of%20radiology&rft.au=Muenzfeld,%20Hanna&rft.date=2019-10&rft.volume=119&rft.spage=108626&rft.epage=108626&rft.pages=108626-108626&rft.artnum=108626&rft.issn=0720-048X&rft.eissn=1872-7727&rft_id=info:doi/10.1016/j.ejrad.2019.07.027&rft_dat=%3Cproquest_cross%3E2280565465%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2280565465&rft_id=info:pmid/31430661&rft_els_id=S0720048X19302700&rfr_iscdi=true